News

Alzheimer’s Prevention Registry Enrolls 40,000 Volunteers in Major Research Project

The Alzheimer’s Prevention Registry recently enrolled the 40,000th volunteer to take part in a major study on Alzheimer’s disease that will be conducted by Banner Alzheimer’s Institute (BAI) in collaboration with other organizations and scientists. The online gateway’s main purpose is to accelerate research by connecting healthy people who are committed to…

Stanford Studies Advance Knowledge on Alzheimer’s Functioning

Even though Alzheimer’s disease is typically only diagnosed in the elderly population, the disease is already present in the brain long before symptoms become visible. Researchers at University of Stanford believe they have found a few promising signs that indicate the early presence of the disease in patients as a result of observing the development…

Study Reveals Alzheimer’s Patients Have Higher Levels of DNA Modifications in Key Gene

A research team from the University of Exeter Medical School and King’s College London has uncovered strong evidence of neurological epigenetic changes leading to Alzheimer Disease (AD) development. There are over 26 million people affected by AD worldwide, a chronic neurodegenerative disorder characterized by progressive neuropathology and cognitive decline. Despite…

Company Uses Intravenous Stem Cells to Successfully Treat Alzheimer’s

An intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells (itMSCs) in a pre-clinical animal model of Alzheimer’s disease has been successfully performed by Stemedica International, a subsidiary of Stemedica Cell Technologies, developing stem cell therapies for Alzheimer’s disease and dementia. The first results of the…

Alzheimer’s Researchers Discover Bryostatin Can Slow, Reverse Disease Progression

Researchers from the Blanchette Rockefeller Neuroscience Institute (BRNI) have gathered evidence of the possible role of protein kinase C epsilon (PKCe) in the treatment of Alzheimer’s disease (AD). The news was recently announced by Neurotrope, a pharmaceutical company collaborating with BRNI in the development of bryostatin, a potent modulator of PKCe,…